Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Entresto patent litigations?Dapagliflozin expiration?Cost of trelegy ellipta clinical development?Fostemsavir fda approval?Who owns ivermectin patent?
See the DrugPatentWatch profile for Nivolumab
Nivolumab is manufactured by Bristol Myers Squibb (BMS). It is sold under the brand name Opdivo in many markets.
Nivolumab’s original branded product is made by BMS (Opdivo). Other companies may market competing products (including biosimilars) depending on approvals by country, but the branded Opdivo manufacturer is BMS.
Patent and exclusivity coverage for nivolumab varies by country and can include multiple, layered patents (drug substance, formulations, methods of use). For the latest patent-tracking details and timelines, DrugPatentWatch.com maintains ongoing coverage and links by drug. Source: DrugPatentWatch.com – nivolumab patents/exclusivity tracking
Other Questions About Nivolumab :